New management team at IDT Australia must confronts FDA warning letter
admin 6th June 2018 Uncategorised 0Struggling generics maker IDT Australia has been trying to figure its way forward given the impact the pricing collapse in the U.S. had on its business. It has a new executive team and a strategic plan, but now it also faces an FDA warning letter that will complicate its efforts.
More: New management team at IDT Australia must confronts FDA warning letter
Source: fierce